Anthem Blue Cross Blue Shield of Colorado prior authorization, page 74

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J9064Injection, cabazitaxel (Sandoz), not therapeutically equivalent to J9043, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9118Injection, calaspargase pegol-mknl, 10 unitsColorado Prior Authorization List, Pg 160 Original policy
J9119Injection, cemiplimab-rwlc, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihjColorado Prior Authorization List, Pg 160 Original policy
J9145Injection, daratumumab, 10 mgColorado Prior Authorization List, Pg 160 Original policy
J9161Injection, denileukin diftitox-cxdl, 1 mcgColorado Prior Authorization List, Pg 160 Original policy
J9173Injection, durvalumab, 10 mgColorado Prior Authorization List, Pg 160 Original policy
J9176Injection, elotuzumab, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9177Injection, enfortumab vedotin-ejfv, 0.25 mgColorado Prior Authorization List, Pg 160 Original policy
J9179Injection, eribulin mesylate, 0.1 mgColorado Prior Authorization List, Pg 160 Original policy
J9183Gemcitabine intravesical system, 225 mgColorado Prior Authorization List, Pg 160 Original policy
J9202Goserelin Acetate ImplantColorado Prior Authorization List, Pg 160 Original policy
J9203Injection, gemtuzumab ozogamicin, 0.1 mgColorado Prior Authorization List, Pg 160 Original policy
J9207Injection, ixabepilone, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9210Injection, emapalumab-lzsg, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9216Injection, interferon, gamma-1B, 3 million unitsColorado Prior Authorization List, Pg 160 Original policy
J9217Leuprolide Acetate SuspnsionColorado Prior Authorization List, Pg 160 Original policy
J9223Injection, lurbinectedin, 0.1 mgColorado Prior Authorization List, Pg 160 Original policy
J9226Histrelin implant (supprelin LA), 50 mgColorado Prior Authorization List, Pg 160 Original policy
J9227Injection, isatuximab-irfc, 10 mgColorado Prior Authorization List, Pg 160 Original policy
J9228Injection, ipilimumab, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9229Injection, inotuzumab ozogamicin, 0.1 mgColorado Prior Authorization List, Pg 160 Original policy
J9248Injection, melphalan (Hepzato), 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9256Injection, nipocalimab-aahu, 3 mgColorado Prior Authorization List, Pg 160 Original policy
J9262Injection, omacetaxine mepesuccinate, 0.01 mgColorado Prior Authorization List, Pg 160 Original policy
J9264Injection, paclitaxel protein-bound particles, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9266Injection, pegaspargase, per single dose vialColorado Prior Authorization List, Pg 160 Original policy
J9269Injection, tagraxofusp-erzs, 10 microgramsColorado Prior Authorization List, Pg 160 Original policy
J9271Injection, pembrolizumab, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9272Injection, dostarlimab-gxly, 10 mgColorado Prior Authorization List, Pg 160 Original policy
J9273Injection, tisotumab vedotin-tftv, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9274Injection, tebentafusp-tebn, 1 microgramColorado Prior Authorization List, Pg 160 Original policy
J9275Injection, cosibelimab-ipdl, 2 mgColorado Prior Authorization List, Pg 160 Original policy
J9276Injection, zanidatamab-hrii, 2 mgColorado Prior Authorization List, Pg 160 Original policy
J9277Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmphColorado Prior Authorization List, Pg 160 Original policy
J9281Mitomycin pyelocalyceal instillation, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9282Mitomycin, intravesical instillation, 1 mgColorado Prior Authorization List, Pg 160 Original policy
J9286Injection, glofitamab-gxbm, 2.5 mgColorado Prior Authorization List, Pg 161 Original policy
J9289Injection, nivolumab, 2 mg and hyaluronidase-nvhyColorado Prior Authorization List, Pg 161 Original policy
J9292Injection, pemetrexed dipotassium, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9294Injection, pemetrexed (Hospira), not therapeutically equivalent to J9305, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9296Injection, pemetrexed (Accord), not therapeutically equivalent to J9305, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9297Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9298Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mgColorado Prior Authorization List, Pg 161 Original policy
J9299Injection, nivolumab, 1 mgColorado Prior Authorization List, Pg 161 Original policy
J9301Injection, obinutuzumab, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9302Injection, ofatumumab, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9303Injection, panitumumab, 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9304Injection, pemetrexed (pemfexy), 10 mgColorado Prior Authorization List, Pg 161 Original policy
J9305Injection, pemetrexed, NOS,10 mgColorado Prior Authorization List, Pg 161 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.